Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01764464 · ClinicalTrials.gov registry record · Phase 4
GRASSP: Gralise® for Spine Surgery Pain
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 53
- Enrollment target
NCT01764464 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 53 participants.
The verdict
NCT01764464, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 53 participants
- Enrollment target
Study Summary
Evaluate the analgesic benefit of Gralise® for post-laminectomy pain syndrome (PLPS)
Interventions
- DRUG Placebo
- DRUG Gralise®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01764464
The ClinicalTrials.gov registry entry for NCT01764464 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01764464 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01764464 about?
NCT01764464 is a clinical study titled "GRASSP: Gralise® for Spine Surgery Pain". Evaluate the analgesic benefit of Gralise® for post-laminectomy pain syndrome (PLPS)
What is the current status of trial NCT01764464?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2012-12. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01764464?
The interventions under investigation include: Placebo (DRUG), Gralise® (DRUG).
Who is sponsoring clinical trial NCT01764464?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.